A controlled trial of recombinant human erythropoietin after bone marrow transplantation.


Recombinant human erythropoietin (rHuEPO) stimulates erythropoietic bone marrow cells and increases erythrocyte production. This prospective study was designed to evaluate the effects of rHuEPO on regeneration of erythropoiesis after allogeneic or autologous bone marrow transplantation (BMT). Seventeen centers participated in this randomized, double-blind… (More)


4 Figures and Tables

Slides referencing similar topics